9-22118103-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000643286.1(CDKN2B-AS1):​n.516T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0218 in 152,384 control chromosomes in the GnomAD database, including 153 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.022 ( 153 hom., cov: 32)
Exomes 𝑓: 0.010 ( 0 hom. )

Consequence

CDKN2B-AS1
ENST00000643286.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.205

Publications

13 publications found
Variant links:
Genes affected
CDKN2B-AS1 (HGNC:34341): (CDKN2B antisense RNA 1) This gene is located within the CDKN2B-CDKN2A gene cluster at chromosome 9p21. The gene product is a functional RNA molecule that interacts with polycomb repressive complex-1 (PRC1) and -2 (PRC2), leading to epigenetic silencing of other genes in this cluster. This region is a significant genetic susceptibility locus for cardiovascular disease, and has also been linked to a number of other pathologies, including several cancers, intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma. Multiple alternatively processed transcript variants have been detected, some of which may take the form of circular RNA molecules (PMID:21151960). [provided by RefSeq, May 2014]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000643286.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000643286.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2B-AS1
NR_003529.4
MANE Select
n.2909-541T>G
intron
N/A
CDKN2B-AS1
NR_047532.2
n.1698-541T>G
intron
N/A
CDKN2B-AS1
NR_047534.2
n.962-541T>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2B-AS1
ENST00000428597.7
TSL:1 MANE Select
n.2909-541T>G
intron
N/A
CDKN2B-AS1
ENST00000422420.3
TSL:1
n.300-2097T>G
intron
N/A
CDKN2B-AS1
ENST00000577551.5
TSL:1
n.610-541T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0218
AC:
3318
AN:
152164
Hom.:
153
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0446
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00681
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.188
Gnomad SAS
AF:
0.0682
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.0143
GnomAD4 exome
AF:
0.0100
AC:
1
AN:
100
Hom.:
0
Cov.:
0
AF XY:
0.0161
AC XY:
1
AN XY:
62
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
4
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.500
AC:
1
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
38
Other (OTH)
AF:
0.00
AC:
0
AN:
4
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0218
AC:
3322
AN:
152284
Hom.:
153
Cov.:
32
AF XY:
0.0228
AC XY:
1698
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0445
AC:
1851
AN:
41562
American (AMR)
AF:
0.00680
AC:
104
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3464
East Asian (EAS)
AF:
0.188
AC:
972
AN:
5164
South Asian (SAS)
AF:
0.0683
AC:
329
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000456
AC:
31
AN:
68024
Other (OTH)
AF:
0.0151
AC:
32
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
152
304
457
609
761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0222
Hom.:
22
Bravo
AF:
0.0231
Asia WGS
AF:
0.0890
AC:
308
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.6
DANN
Benign
0.71
PhyloP100
0.20

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs17761446;
hg19: chr9-22118102;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.